Replies to post #29681 on Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Living, you stated: " I also think the agreement is continuing."

If the agreement with UNI is still continuing, why then did UNI cease working on the patent application and let it die?

Are you attempting to "cherry pick" the agreement to claim it is continuing? Or is the null and void because the patents have expired just as was stated in the agreement?

[jimtash]

Someone will sell the test here in the USA.

[jimtash]

I'll even toss out that Radient is now a subsidiary of Arima/Uni or something along those lines. Especially considering that the majority of the shares are not owned by anyone on the BOD.

[GetSeriousOK]

The two merger theories contradict each other. The only thing they have in common: they are both absurd.

One theory has some private investors owning a majority in both Provista and Radient. These "Angel Investors" supposedly sabotaged Radient Pharmaceuticals over four years so they could buy shares cheaper. They will now apparently force Provista to merge with Radient.

The other theory has Arima owning a majority of Radient and UNI still paying $100,000 per year to AMDL Diagnostics even though they are no longer contractually requried to do so. The prize here for both Arima and UNI: DR-70, a tumor marker that the global medical community rejected and is now off patent.

And in both cases, $20 million debt is waiting for any prospective new owner of Radient Pharmaceuticals. The "Provista theory" claims that the debt magically disappeared because the lenders felt magnanimous, while the "Arima theory" simply pretends that debt doesn't exist.

LOL, indeed.